ONCO logo

Onconetix (ONCO) EBIT

Annual EBIT

-$36.75 M
-$23.33 M-173.85%

December 31, 2023


Summary


Performance

ONCO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCOprofitabilitymetrics:

Quarterly EBIT

-$3.50 M
+$10.40 M+74.82%

September 30, 2024


Summary


Performance

ONCO Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCOprofitabilitymetrics:

TTM EBIT

-$50.40 M
+$1.58 M+3.04%

September 30, 2024


Summary


Performance

ONCO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCOprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ONCO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-173.8%+67.7%-12.7%
3 y3 years-2165.6%+67.7%-12.7%
5 y5 years-4075.3%+67.7%-12.7%

ONCO EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-975.4%at low-190.7%+84.2%-1374.7%+3.0%
5 y5-year-4075.3%at low-973.9%+84.2%<-9999.0%+3.0%
alltimeall time-4075.3%at low-973.9%+84.2%<-9999.0%+3.0%

Onconetix EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.50 M(-74.8%)
-$50.40 M(-3.0%)
Jun 2024
-
-$13.89 M(+28.3%)
-$51.97 M(+16.2%)
Mar 2024
-
-$10.83 M(-51.2%)
-$44.73 M(+21.7%)
Dec 2023
-$36.75 M(+173.9%)
-$22.17 M(+336.7%)
-$36.75 M(+106.5%)
Sep 2023
-
-$5.08 M(-23.7%)
-$17.79 M(+7.3%)
Jun 2023
-
-$6.65 M(+133.7%)
-$16.58 M(+16.8%)
Mar 2023
-
-$2.85 M(-11.5%)
-$14.20 M(+5.8%)
Dec 2022
-$13.42 M
-
-
Dec 2022
-
-$3.22 M(-16.8%)
-$13.42 M(+17.7%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$3.87 M(-9.3%)
-$11.41 M(+32.1%)
Jun 2022
-
-$4.26 M(+105.9%)
-$8.63 M(+67.3%)
Mar 2022
-
-$2.07 M(+72.1%)
-$5.16 M(+51.1%)
Dec 2021
-$3.42 M(+110.7%)
-$1.20 M(+9.8%)
-$3.42 M(+30.5%)
Sep 2021
-
-$1.10 M(+38.3%)
-$2.62 M(+71.9%)
Jun 2021
-
-$792.30 K(+143.2%)
-$1.52 M(+108.4%)
Mar 2021
-
-$325.80 K(-19.6%)
-$731.20 K(+80.4%)
Dec 2020
-$1.62 M(+84.3%)
-$405.40 K
-$405.40 K
Dec 2019
-$880.20 K
-
-

FAQ

  • What is Onconetix annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Onconetix?
  • What is Onconetix annual EBIT year-on-year change?
  • What is Onconetix quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Onconetix?
  • What is Onconetix quarterly EBIT year-on-year change?
  • What is Onconetix TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Onconetix?
  • What is Onconetix TTM EBIT year-on-year change?

What is Onconetix annual earnings before interest & taxes?

The current annual EBIT of ONCO is -$36.75 M

What is the all time high annual EBIT for Onconetix?

Onconetix all-time high annual earnings before interest & taxes is -$880.20 K

What is Onconetix annual EBIT year-on-year change?

Over the past year, ONCO annual earnings before interest & taxes has changed by -$23.33 M (-173.85%)

What is Onconetix quarterly earnings before interest & taxes?

The current quarterly EBIT of ONCO is -$3.50 M

What is the all time high quarterly EBIT for Onconetix?

Onconetix all-time high quarterly earnings before interest & taxes is -$325.80 K

What is Onconetix quarterly EBIT year-on-year change?

Over the past year, ONCO quarterly earnings before interest & taxes has changed by +$7.33 M (+67.68%)

What is Onconetix TTM earnings before interest & taxes?

The current TTM EBIT of ONCO is -$50.40 M

What is the all time high TTM EBIT for Onconetix?

Onconetix all-time high TTM earnings before interest & taxes is -$405.40 K

What is Onconetix TTM EBIT year-on-year change?

Over the past year, ONCO TTM earnings before interest & taxes has changed by -$5.66 M (-12.66%)